These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. High risk prostate cancer: evolving definition and approach to management. Chughtai B; Mian BM Can J Urol; 2008 Dec; 15(6):4375-80. PubMed ID: 19046490 [TBL] [Abstract][Full Text] [Related]
5. The clinical significance and therapeutic implications of extraprostatic invasion. Foley CL; Feneley MR Surg Oncol; 2009 Sep; 18(3):203-12. PubMed ID: 19398328 [TBL] [Abstract][Full Text] [Related]
6. [Cryoablation for prostate cancer induces tumor-specific immune response]. Si TG; Guo Z; Wang HT; Han YP; Hao XS Zhonghua Nan Ke Xue; 2009 Apr; 15(4):350-3. PubMed ID: 19472911 [TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma in brain tumor immunotherapy. Kane A; Yang I Neurosurg Clin N Am; 2010 Jan; 21(1):77-86. PubMed ID: 19944968 [TBL] [Abstract][Full Text] [Related]
10. Prostate cancer: epidemiology and health-related quality of life. Penson DF; Rossignol M; Sartor AO; Scardino PT; Abenhaim LL Urology; 2008 Dec; 72(6 Suppl):S3-11. PubMed ID: 19095126 [TBL] [Abstract][Full Text] [Related]
11. Prostatic chondroitin sulfate is increased in patients with metastatic disease but does not predict survival outcome. Ricciardelli C; Sakko AJ; Stahl J; Tilley WD; Marshall VR; Horsfall DJ Prostate; 2009 May; 69(7):761-9. PubMed ID: 19189303 [TBL] [Abstract][Full Text] [Related]
12. Prostate cancer in the elderly. Heinzer H; Steuber T Urol Oncol; 2009; 27(6):668-72. PubMed ID: 19879477 [TBL] [Abstract][Full Text] [Related]
13. Towards the definition of prostate cancer-related microRNAs: where are we now? Gandellini P; Folini M; Zaffaroni N Trends Mol Med; 2009 Sep; 15(9):381-90. PubMed ID: 19716766 [TBL] [Abstract][Full Text] [Related]
14. What PCPs and geriatricians need to know about robotic prostatectomy and organ-confined prostate cancer. Carlucci JR; Nabizada-Pace F; Samadi DB Geriatrics; 2009 Feb; 64(2):8-14. PubMed ID: 19256581 [TBL] [Abstract][Full Text] [Related]
15. The current state of brachytherapy nomograms for patients with clinically localized prostate cancer. Nguyen CT; Zelefsky MJ; Kattan MW Cancer; 2009 Jul; 115(13 Suppl):3121-7. PubMed ID: 19544540 [TBL] [Abstract][Full Text] [Related]
16. PSA testing and DRE, TRUS scanning with sector biopsy, improved histology, curative treatments, and active surveillance for prostate cancer: a success story for men's health. Smart R N Z Med J; 2008 Dec; 121(1287):57-68. PubMed ID: 19098969 [TBL] [Abstract][Full Text] [Related]
17. Quality of life outcomes following treatment for localized prostate cancer: is there a clear winner? Parker WR; Montgomery JS; Wood DP Curr Opin Urol; 2009 May; 19(3):303-8. PubMed ID: 19300266 [TBL] [Abstract][Full Text] [Related]
18. Androgen deprivation therapy for advanced prostate cancer: why does it fail and can its effects be prolonged? Singer EA; Golijanin DJ; Messing EM Can J Urol; 2008 Dec; 15(6):4381-7. PubMed ID: 19046491 [TBL] [Abstract][Full Text] [Related]
19. Salvage radical prostatectomy for recurrent prostate cancer after radiation therapy. Leonardo C; Simone G; Papalia R; Franco G; Guaglianone S; Gallucci M Int J Urol; 2009 Jun; 16(6):584-6. PubMed ID: 19453762 [TBL] [Abstract][Full Text] [Related]